Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer

[11] Ye X(2009) and Ann Oncol 20 736-734

[12] Sawyer MB(2010) for individualized irinotecan chemotherapy Int J Clin Pharmacol Ther 48 729-486

[13] Damaraju S(2007)Single nucleotide polymorphisms and haplotype frequencies of Curr Drug Metab 8 481-5528

[14] Pituskin E(2009) and J Clin Oncol 27 5519-472

[15] Damaraju V(2006) in a Japanese population Br J Clin Pharmacol 62 457-280

[16] Scarfe AG(1998)Glutathione Carcinogenesis 19 275-94

[17] Bies RB(1999)-transferase P1 polymorphisms (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy Arch Biochem Biophys 366 89-1334

[18] Dirven HA(1999)Relationship between GSTP1 Ile (105) Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity EMBO J 18 1321-574

[19] van Ommen B(2003)Association between oxaliplatin-induced peripheral neuropathy and polymorphisms of the Clin Pharmacol Ther 73 566-184

[20] Van Bladeren PJ(2010) and Ther Drug Monit 32 177-undefined

[11] Ye X(2009) and Ann Oncol 20 736-734

[12] Sawyer MB(2010) for individualized irinotecan chemotherapy Int J Clin Pharmacol Ther 48 729-486

[13] Damaraju S(2007)Single nucleotide polymorphisms and haplotype frequencies of Curr Drug Metab 8 481-5528

[14] Pituskin E(2009) and J Clin Oncol 27 5519-472

[15] Damaraju V(2006) in a Japanese population Br J Clin Pharmacol 62 457-280

[16] Scarfe AG(1998)Glutathione Carcinogenesis 19 275-94

[17] Bies RB(1999)-transferase P1 polymorphisms (Ile105Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy Arch Biochem Biophys 366 89-1334

[18] Dirven HA(1999)Relationship between GSTP1 Ile (105) Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity EMBO J 18 1321-574

[19] van Ommen B(2003)Association between oxaliplatin-induced peripheral neuropathy and polymorphisms of the Clin Pharmacol Ther 73 566-184

[20] Van Bladeren PJ(2010) and Ther Drug Monit 32 177-undefined